Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer gene therapy.

F A Ferrer1, R Rodriguez

  • 1The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland 21287-2101, USA.

Hematology/Oncology Clinics of North America
|August 30, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Objective pain assessment after ureteral reimplantation: comparison of open versus robotic approach.

Journal of pediatric urology·2015
Same author

Image based feasibility of renal sparing surgery for very low risk unilateral Wilms tumors: a report from the Children's Oncology Group.

The Journal of urology·2013
Same author

Observations on the clinical picture of otitic hydrocephalus in relation to a personal case.

Revista clinica espanola·2010
Same author

Modified Young-Dees-Leadbetter bladder neck reconstruction: new concepts about old ideas.

Urology·2001
Same author

Survey results on medical and surgical followup of patients with vesicoureteral reflux from American Association of Pediatrics, Section on Urology members.

The Journal of urology·2001
Same author

Citrobacter diversus urosepsis and cerebral abscess in a child with antenatal hydronephrosis.

Urology·2001
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Cancer gene therapy shows promise but faces challenges in gene transfer efficiency and vector immunogenicity. Future research will focus on combination therapies, aiming to make gene therapy a standard cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Cancer-specific gene therapy is an emerging field with early-stage development.
  • Despite initial trials in the late 1980s, significant progress has been slow.
  • Recent successes in treating genetic diseases highlight gene therapy's potential.

Purpose of the Study:

  • To address the current limitations in cancer-specific gene therapy.
  • To explore the future directions and potential of gene therapy in oncology.
  • To emphasize the need for advancements in gene transfer technology.

Main Methods:

  • Review of existing gene therapy paradigms (ex vivo and in vivo).
  • Discussion of challenges including gene transfer efficiency and vector immunogenicity.

Related Experiment Videos

  • Exploration of combination therapy strategies with conventional treatments.
  • Main Results:

    • Current gene transfer methods face efficiency and immunological hurdles.
    • Successful cancer gene therapy will likely integrate ex vivo and in vivo approaches.
    • Future trials are expected to combine gene therapy with chemotherapy, differentiating agents, or radiation.

    Conclusions:

    • Overcoming technical obstacles in gene transfer is crucial for advancing gene therapy.
    • Gene therapy holds significant potential to become a standard treatment for cancer.
    • The development of gene-based therapeutics (molecular medicine) is a formidable but achievable goal.